Consider automation early in the rollout of clinical translation and scale up of clinical-trial protocols.
James B Morrissey
Advertisement
James B Morrissey is bioengineering scientist-Cocoon Program, Octane Biotech Inc.
Articles by James B Morrissey
Advertisement
Latest Updated Articles
End-to-End Cell Therapy Automation: An Immunotherapy Case StudySeptember 15th 2017
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
3
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
4
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
5